Warc7 个月
Beyfortus: All in for all infant protection – a sell-out RSV immunisation story
Sanofi, a global healthcare and pharmaceutical company, developed Beyfortus, a new immunisation for babies against Respiratory Syncytial Virus (RSV), launching it internationally and taking an ...
pharmaphorum12 个月
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
AstraZeneca and Sanofi’s long-acting antibody Beyfortus has been approved in China for the prevention of respiratory syncytial virus (RSV) infections in newborns and infants, opening up a major ...